Wouter M

Fellow of nephrology at LUMC Leiden
N-PATH fellow
PhD candidate

[Biomedicines MDPI @Biomed_MDPI]

🫘Unveiling Donor-Derived BKPyV DNAemia Through Analysis of Contralateral Kidney Transplant Recipients
https://t.co/HIWJ8nRJd1
Evaluating donor-derived factors in BKPyV transmission in kidney transplants #KidneyTransplant #BKPyV @W_Moest @jirotmans @MarietFeltkamp

[Gregor Bond @BondGregor]

First data of the TTVguideIT RCT
presented @ERA26 in Glasgow 🏴󠁧󠁢󠁳󠁣󠁴󠁿

Personalized Immunosuppression 💊 by Torque Teno 🦠 virus in kidney TX is safe and might help reducing Tacrolimus #TTVguide

[Gregor Bond @BondGregor]

we did it 👏🍾🎉🕺💃☺️

today was last visit of the last patient of the TTVguideIT study

260 KTX recipients randomiced to torque teno virus 🦠 guided immunosuppression vs SOC and followed for one year

thanks to all 13 recruiting centers across europe #ttvguide

[Raquel Barba Teba 🦋 @DrBarbaTeba]

The @vasyoungcom is present at the #VAS2025! See you all at the sessions coming this very day

[VAS Young Committee @vasyoungcom]

📣Article of the month 📢“The arteriovenous access stage (AVAS) classification” by Baláž et al. They report on a new classification system to describe a patient’s suitability and options for upper limb VA creation based on arterial and venous anatomy
https://t.co/qyzP7rNpC6

[Wouter M @W_Moest]

📣Watch out for de novo DSA formation after high-load BKPyV DNAemia in kidney transplant recipients! Should we rethink immunosuppression reduction in these cases? Could #TTVGuide help balance rejection/infection? @jirotmans @MarietFeltkamp @BondGregor https://t.co/ZKvxfY1M58

[VAS Young Committee @vasyoungcom]

📣Case of the month📣
Patient presents with some complaints of a cold hand, without pain, after creation of radiocephalic fistula (grade I Haemodialysis access-induced distal ischaemia (HAIDI).

[VAS Young Committee @vasyoungcom]

📣Case of the month📢
Complex access cases where patients have exhausted traditional upper limb options or have central venous disease still have vascular access options beyond central venous catheters or lower limb access ⬇️⬇️⬇️

[VAS Young Committee @vasyoungcom]

1/6 📢Article of the month📣
'Association of Frailty with Postoperative Survival and Outcomes Following Hemodialysis Vascular Access Creation' by Karissa M. Wang and colleague's
https://t.co/Iszzhenuau

[Wouter M @W_Moest]

https://t.co/MRKDRZ37fZ

[Wouter M @W_Moest]

📢Check out our latest article📣 Revealing how Belatacept counteracts the decline of TTV levels in kidney transplant patients.Could Belatacept be a more potent immunosuppressant than we think?Thanks to #TTVguide and @biomerieux
@jirotmans @MarietFeltkamp @BondGregor @owbredewold

[Gregor Bond @BondGregor]

today the last of 260 patients for the TTVguideIT trial #ttvguide was randomized 😊

this multicenter interventional RCT tests if Torque Teno virus 🦠 guided immunosuppression can improve kidney TX outcome

🙏 to 13 including centers across Europe

data expected 9/25

[VAS Young Committee @vasyoungcom]

📢Article of the month🔔 ‘Ultrasound evaluation of dialysis access-related distal ischaemia’ by Pirozzi et al.https://t.co/VK1kuAlCYK
Key points:Ultrasound helps confirm the diagnosis of HD access-induced distal ischaemia (HAIDI) and determine the right procedure for treatment

[VAS Young Committee @vasyoungcom]

🌟 Welcome to VAS Young Committee!🌟 Join us as we dive into the world of vascular access for dialysis, connecting young professionals with latest insights, innovations, and opportunities. Stay tuned for expert tips and inspiring stories.#YoungProfessionals #VascularAccessSociety

[Wouter M @W_Moest]

🎉 Exciting news @ttvguidetx!We've reached our randomization goal for the TTV study in the footsteps of @CHU_Grenoble!Thanks to @jirotmans @MarietFeltkamp for their invaluable support and to @BondGregor @fredhaupenthal for their guidance Onward and upward! 🚀 #TTVguide

[Wouter M @W_Moest]

Created a fortress of a folder on the department drive, locked it tight for only a select few and forgot to include myself to the VIP list. Now it stands, I'm afraid until the end of time..#PhDlife

[Mariet Feltkamp @MarietFeltkamp]

@LUMC_Leiden is happy to contribute to this important clinical trial #ttvguide #TTV #immunometer

@jirotmans @W_Moest @CarolinevdB

[Louis Firket 🇧🇪 @FirketLouis]

Despite the end of @NPATH15, we show that it's only the beginning with this Editorial of our experience in #JVA. @SocietyAccess
Special thanks to @MGallieni for the his support 👏
@DrBarbaTeba @FiSFerreira @Stones__ @W_Moest @LideLopez6 @GeorgopGeorgia
https://t.co/qA9WQD4l6m

[Wouter M @W_Moest]

Already the last module of the @NPATH15 program! Thanks to the amazing nephrology team at the General University Hospital of Patras I learned a lot about peritoneale dialysis!! And their hospitality...Amazing!!

[Wouter M @W_Moest]

Welcome to the future of vascular access with the dynamic AVF #VAS2023. Great work done by my colleague Nick and others @LUMC_Leiden.